Steven Cohen’s CorMedix CRMD Stock Holding History

Steven Cohen’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-28,039	Closed	-$345K	–	2371
2025 Q2	$345K	Buy	+28,039	New	+$310K	﹤0.01%	1883
2023 Q2	–	Sell	-69	Closed	-$286	–	2262
2023 Q1	$286	Buy	+69	New	+$282	﹤0.01%	2148

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steven Cohen's CRMD Position: Q3 2025 in Review

Steven Cohen sold out of CorMedix (CRMD) in Q3 2025, closing a stake of 28,039 shares — an estimated $345K sold.

Steven Cohen first reported a position in CRMD in Q1 2023 and held it in 2 quarters. The position peaked at $345K in Q2 2025. 190 funds tracked by Wall St. Rank hold CRMD as of Q3 2025.

Steven Cohen reported no remaining CorMedix position as of Q3 2025 after selling out during the quarter.
Steven Cohen sold 28,039 CorMedix shares in Q3 2025, an estimated $345K.
Steven Cohen first reported a position in CorMedix in Q1 2023 and held it in 2 quarters.
Steven Cohen's CorMedix position peaked at $345K in Q2 2025.
190 funds tracked by Wall St. Rank held CorMedix as of Q3 2025.

Based on Point72 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.